These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7545424)

  • 1. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity.
    Ferster A; Corazza F; Vertongen F; Bujan W; Devalck C; Fondu P; Cochaux P; Lambermont M; Khaladji Z; Sariban E
    Br J Haematol; 1995 Aug; 90(4):804-8. PubMed ID: 7545424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.
    Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA
    Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrollees.
    Mahesri M; Schneeweiss S; Globe D; Mutebi A; Bohn R; Achebe M; Levin R; Desai RJ
    Eur J Haematol; 2021 Feb; 106(2):273-280. PubMed ID: 33155319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for severe sickle cell anaemia.
    Ferster A; De Valck C; Azzi N; Fondu P; Toppet M; Sariban E
    Br J Haematol; 1992 Jan; 80(1):102-5. PubMed ID: 1536796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemoglobin F and clinical severity of sickle cell anaemia among Nigerian adults.
    Kotila TR; Fawole OI; Shokunbi WA
    Afr J Med Med Sci; 2000; 29(3-4):229-31. PubMed ID: 11713996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease.
    Lessard S; Rimmelé P; Ling H; Moran K; Vieira B; Lin YD; Rajani GM; Hong V; Reik A; Boismenu R; Hsu B; Chen M; Cockroft BM; Uchida N; Tisdale J; Alavi A; Krishnamurti L; Abedi M; Galeon I; Reiner D; Wang L; Ramezi A; Rendo P; Walters MC; Levasseur D; Peters R; Harris T; Hicks A
    Sci Rep; 2024 Oct; 14(1):24298. PubMed ID: 39414860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained and full fetal hemoglobin production after failure of bone marrow transplant in a patient homozygous for beta 0-thalassemia: a clinical remission despite genetic disease and transplant rejection.
    Paciaroni K; Gallucci C; De Angelis G; Alfieri C; Roveda A; Lucarelli G
    Am J Hematol; 2009 Jun; 84(6):372-3. PubMed ID: 19373892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal haemoglobin induction in sickle cell disease.
    Paikari A; Sheehan VA
    Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foetal haemoglobin in homozygous sickle cell disease: a study of patients with low HBF levels.
    Donaldson A; Thomas P; Serjeant BE; Serjeant GR
    Clin Lab Haematol; 2001 Oct; 23(5):285-9. PubMed ID: 11703409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of fetal hemoglobin on the clinical expression of sickle cell anemia.
    Powars DR; Chan L; Schroeder WA
    Ann N Y Acad Sci; 1989; 565():262-78. PubMed ID: 2476064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results and current indications of bone marrow allograft in sickle cell disease].
    Bernaudin F
    Pathol Biol (Paris); 1999 Jan; 47(1):59-64. PubMed ID: 10081781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
    Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
    JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for sickle cell anemia.
    Abboud MR; Jackson SM; Barredo J; Beatty J; Laver J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):86-9. PubMed ID: 8311178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuation of fetal hemoglobin in sickle-cell anemia.
    Morrison JC; Whybrew WD; Bucovaz ET; Wiser WL
    Am J Obstet Gynecol; 1976 Aug; 125(8):1085-8. PubMed ID: 952305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
    Walters MC; Patience M; Leisenring W; Rogers ZR; Dinndorf P; Davies SC; Roberts IA; Yeager A; Kurtzberg J; Bunin N; Scott JP; Wall DA; Wayne AS; Wiley J; Darbyshire PJ; Mentzer WC; Smith FO; Sullivan KM
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):310-5. PubMed ID: 9502298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in sickle cell disease: the Belgian experience.
    Vermylen C; Cornu G; Ferster A; Ninane J; Sariban E
    Bone Marrow Transplant; 1993; 12 Suppl 1():116-7. PubMed ID: 8374550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation for sickle cell disease. The European experience.
    Vermylen C; Cornu G
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):18-21. PubMed ID: 8311167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
    Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
    BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.